DxVx

Company Deals

DxVx Secures License for OVM-200 Anti-Cancer Vaccine from Oxford Vacmedix

Fineline Cube Nov 27, 2023

South Korea-based DxVx is poised to license OVM-200 from Oxford Vacmedix (OVM), with plans to...

Company Drug

China Medical System’s Silvemimab Becomes World’s First Dual-Epitope Fully Human Rabies Antibody Approved in China

Company Deals

Fusen Pharmaceutical Secures RMB 300M Strategic Investment for Henan Subsidiary Debt Restructuring and Working Capital

Company Drug

Biokin Secures World’s First EGFR×HER3 Bispecific ADC Approval with Loncomystatug Deruxtecan for Nasopharyngeal Carcinoma

Policy / Regulatory

China Launches 12th National Drug Volume-Based Procurement Batch with 65 Products, Patent Disputes Highlighted